DOCSLIB.ORG

Deciphering the Proteolytic Mechanism of the Atp-Dependent

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

DECIPHERING THE PROTEOLYTIC MECHANISM OF THE ATP-DEPENDENT PROTEASE LON USING FLUORESCENT PEPTIDES by JESSICA WARD Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Thesis Adviser: Dr. Irene Lee Department of Chemistry CASE WESTERN RESERVE UNIVERSITY January, 2008 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of ______________________________________________________ candidate for the ________________________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. TABLE OF CONTENTS Title page…………………………………………………………………………………..i Committee Sign-off sheet…………………………………………………………............ii Table of Contents…………………………………………………………………………iii List of Tables…………………………………………………………………………….vii List of Figures…………………………………………………………………………...viii Acknowledgements………………………………………………………………………xii List of Abbreviations……………………………………………………………………xiii Abstract………………………………………………………………………………….xvi CHAPTER 1 Introduction to Lon protease……………..…………………………………1 CHAPTER 2 Evaluating the contributions of nucleotide binding and hydrolysis towards the proteolytic activity of E. coli Lon protease…………………………………..11 2.1 Introduction…………………………………………………………………..12 2.2 Methods and Materials……………………………………………………….15 2.2.1 Peptidase activity with various nucleotides………………………..15 2.2.2 Peptidase activity with limiting ATP……………………………....16 2.3 Results and Discussion………………………………………………………17 2.3.1 Peptidase activity with various nucleotides………………………..17 2.3.2 Peptidase activity with limiting ATP………………………………22 2.4 Conclusions…………………………………………………………………..24 CHAPTER 3 Pre-steady-state kinetic characterization of the peptidase activity of E. coli Lon protease……………………………………………………………………...28 3.1 Introduction…………………………………………………………………..29 iii 3.2 Methods and Materials……………………………………………………….32 3.2.1 Measuring peptide hydrolysis using a discontinuous acid-quench assay……………………………………………………………...32 3.2.2 Pre-steady-state kinetic analysis of peptide hydrolysis……………32 3.2.3 ADP inhibition of the lag phase in peptide hydrolysis…………….34 3.3 Results and Discussion………………………………………………………36 3.3.1 Measuring peptide hydrolysis using a discontinuous acid-quench assay……………………………………………………………..36 3.3.2 Pre-steady-state kinetic analysis of peptide hydrolysis……………37 3.3.3 ADP inhibition of the lag phase in peptide hydrolysis…………….43 3.4 Conclusions…………………………………………………………………..46 CHAPTER 4 Investigating the mechanism of E. coli Lon protease using proteolytically inactive Lon mutants……………………………………………………………..50 4.1 Introduction…………………………………………………………………..51 4.2 Methods and Materials……………………………………………………….53 4.2.1 Generation and characterization of Lon mutants…………………..53 4.2.2 Fluorescence emission scans……………………………………….54 4.2.3 Measuring peptide binding using fluorescence anisotropy………...54 4.2.4 Monitoring Lon-peptide interactions using pre-steady-state kinetic techniques………………………………………………………..55 4.2.5 ADP inhibition of the Lon-peptide interaction…………………….58 4.3 Results and Discussion………………………………………………………60 4.3.1 Developing an assay to monitor Lon-peptide interactions………...60 iv 4.3.2 Monitoring the Lon-peptide interaction with S679A using pre- steady-state kinetic techniques…………………………………69 4.3.3 Measuring peptide binding to Lon using fluorescence anisotropy.72 4.3.4 Examining events prior to peptide hydrolysis using S679W and pre-steady-state kinetic techniques…………………………73 4.3.5 ADP inhibition of the Lon-peptide interaction……………………84 4.4 Conclusions………………………………………………………………….86 CHAPTER 5 Exploring the substrate specificity of E. coli Lon protease using peptide substrates and λN protein deletion mutants……………………………………..94 5.1 Introduction………………………………………………………………….95 5.2 Materials and Methods………………………………………………………98 5.2.1 Peptide design and peptidase assays………………………………98 5.2.2 λN purification and generation of λN deletion mutants………….100 5.2.3 λN degradation assay……………………………………………..102 5.3 Results and Discussion……………………………………………………..103 5.3.1 Examining Lon substrate specificity using λN peptides…………103 5.3.2 Alanine scan of λN89-98 peptide………………………………...109 5.3.3 Importance of the C-S cleavage site in the λN89-98 peptide……114 5.3.4 Degradation of a 2-site peptide…………………………………..116 5.3.5 Wild type λN and λN deletion mutant protein purification and degradation……………………………………………………..118 5.4 Conclusions…………………………………………………………………124 CHAPTER 6 Conclusions and future directions……………………………………….127 v Appendix: Jessica Ward’s publications………………………………………………..137 Bibliography……………………………………………………………………………183 vi LIST OF TABLES CHAPTER 2 2.1. Steady-state kinetic parameters of NTP-dependent peptidase activity……………20 2.2 Peptidase activity rate constants at limiting, stoichiometric and saturating nucleotide concentrations…………………………………………………………………..23 2.3 Steady-state kinetic parameters of intrinsic and peptide stimulated NTPase activity…………………………………………………………………25 CHAPTER 3 3.1 Kinetic parameters associated with the pre-steady-state characterization of E. coli Lon protease……………………………………………………………………..41 CHAPTER 4 4.1 Primers used in site-directed mutagenesis…………………………………………..53 4.2 Kinetic parameters for ATP binding and hydrolysis by wildtype and Lon mutants...62 4.3 Kinetic constants for λN89-98 dansyl peptide interacting with S679A and S679W..72 4.4 Experimental and theoretical rate constants for the E. coli Lon mechanism………...93 CHAPTER 5 5.1 Steady-state kinetic parameters for peptidase activity with λN peptides…………..107 5.2 Steady-state kinetic parameters for ATPase activity with λN peptides……………109 5.3 Steady-state kinetic parameters for peptidase activity with λN89-98 alanine scan peptides……………………………………………………………………113 vii LIST OF FIGURES CHAPTER 1 1.1 The domain organization of E. coli Lon protease……………………………………..4 1.2 Proposed Ser-Lys dyad mechanism for peptide bond hydrolysis……………………..5 1.3 Proposed mechanism for E. coli Lon protease………………………………………...6 1.4 E. coli Lon protease mechanism proposed by our lab………………………………...7 1.5 Structures of the fluorescent and non-fluorescent model peptide substrate λN89-98…………………………………………………………………………..9 1.6 Peptidase activity assay………………………………………………………………10 CHAPTER 2 2.1 Chemical structures of nucleotides…………………………………………………..14 2.2 Scheme for ATP and peptide binding to Lon………………………………………..16 2.3 Peptidase activity at varying concentrations of peptide in the presence of saturating ATP, CTP, GTP and UTP…………………………………………….18 2.4 Peptidase activity with saturating peptide at varying concentrations of ATP, CTP, GTP and UTP………………………………………………………..19 2.5 Structures of adenine and cytidine…………………………………………………...21 2.6 Peptidase activity with limiting amounts of ATP or AMPPNP……………………...23 2.7 Limited tryptic digestion of Lon with various nucleotides…………………………..26 2.8 Proposed mechanism for peptide hydrolysis………………………………………...27 CHAPTER 3 3.1 Diagram of stopped-flow and rapid chemical quench……………………………….31 3.2 Monitoring the peptidase reaction using a discontinuous acid-quench assay……….37 viii 3.3 Stopped-flow time courses of peptide hydrolysis by E. coli Lon……………………38 3.4 Steady-state kinetics of peptide cleavage……………………………………………40 3.5 Substrate dependency of the pre-steady-state lag phase in the peptidase reaction…..42 3.6 ADP lengthens the pre-steady-state lag phase of the peptidase reaction…………….44 3.7 ADP inhibits the pre-steady-state of peptide hydrolysis……………………………..45 3.8 Pre-steady-state time courses for ATP hydrolysis and λN89-98 degradation under identical reaction conditions………………………………………………47 3.9 Proposed mechanism for peptide hydrolysis by Lon………………………………...48 CHAPTER 4 4.1 ATPase activity of Lon mutants……………………………………………………..61 4.2 Peptidase activity of Lon mutants……………………………………………………62 4.3 MANT-ATP binding to Lon…………………………………………………………63 4.4 Limited tryptic digestion analysis of S679A, S679W and S679W, W297F, W303F, W603F Lon mutants…………………………………………………...64 4.5 Emission scan of S679A Lon with the λN89-98 NF peptide……………………….65 4.6 Emission scan of S679A Lon with λN89-98 dansyl peptide………………………..66 4.7 Peptide binding to S679A can be monitored using the λN89-98 dansyl peptide and monitoring dansyl fluorescence…………………………………………….68 4.8 Peptide binding to S679A can be monitored using the λN89-98 dansyl peptide and monitoring tryptophan fluorescence…………………………………………….68 4.9 λN89-98 dansyl peptide binding to S679A is dependent on peptide……………….70 4.10 Scheme for peptide binding to Lon………………………………………………..70 4.11 λN89-98 dansyl peptide binding to S679A is dependent on ATP…………………71 ix 4.12 Equilibrium λN89-98 dansyl binding to Lon can be monitored using fluorescence anisotropy………………………………………………………………………..73 4.13 Intrinsic tryptophan fluorescence can be used to measure a conformational change in S679W dependent on ATP and AMPPNP…………………………………….75 4.14 Representative time courses for S679W interacting with the λN89-98 dansyl peptide at varying concentrations of ATP……………………………………….76 4.15 Representative time courses for S679W interacting with the λN89-98 dansyl peptide at varying concentrations of λN89-98 dansyl peptide…………………..78 4.16 The first phase of the S679W reaction is dependent on ATP………………………79
Recommended publications
  • The Proteasome: a Proteolytic Nanomachine of Cell Regulation and Waste Disposal

    The Proteasome: a Proteolytic Nanomachine of Cell Regulation and Waste Disposal

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1695 (2004) 19–31 http://www.elsevier.com/locate/bba Review The proteasome: a proteolytic nanomachine of cell regulation and waste disposal Dieter H. Wolf *, Wolfgang Hilt Institut fu¨r Biochemie, Universita¨t Stuttgart, Pfaffenwaldring 55, 70569 Stuttgart, Germany Available online 26 October 2004 Abstract The final destination of the majority of proteins that have to be selectively degraded in eukaryotic cells is the proteasome, a highly sophisticated nanomachine essential for life. 26S proteasomes select target proteins via their modification with polyubiquitin chains or, in rare cases, by the recognition of specific motifs. They are made up of different subcomplexes, a 20S core proteasome harboring the proteolytic active sites hidden within its barrel-like structure and two 19S caps that execute regulatory functions. Similar complexes equipped with PA28 regulators instead of 19S caps are a variation of this theme specialized for the production of antigenic peptides required in immune response. Structure analysis as well as extensive biochemical and genetic studies of the 26S proteasome and the ubiquitin system led to a basic model of substrate recognition and degradation. Recent work raised new concepts. Additional factors involved in substrate acquisition and delivery to the proteasome have been discovered. Moreover, first insights in the tasks of individual subunits or subcomplexes of the 19S caps in substrate recognition and binding as well as release and recycling of polyubiquitin tags have been obtained. D 2004 Elsevier B.V. All rights reserved.
  • Molecular Markers of Serine Protease Evolution

    Molecular Markers of Serine Protease Evolution

    The EMBO Journal Vol. 20 No. 12 pp. 3036±3045, 2001 Molecular markers of serine protease evolution Maxwell M.Krem and Enrico Di Cera1 ment and specialization of the catalytic architecture should correspond to signi®cant evolutionary transitions in the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Box 8231, St Louis, history of protease clans. Evolutionary markers encoun- MO 63110-1093, USA tered in the sequences contributing to the catalytic apparatus would thus give an account of the history of 1Corresponding author e-mail: [email protected] an enzyme family or clan and provide for comparative analysis with other families and clans. Therefore, the use The evolutionary history of serine proteases can be of sequence markers associated with active site structure accounted for by highly conserved amino acids that generates a model for protease evolution with broad form crucial structural and chemical elements of applicability and potential for extension to other classes of the catalytic apparatus. These residues display non- enzymes. random dichotomies in either amino acid choice or The ®rst report of a sequence marker associated with serine codon usage and serve as discrete markers for active site chemistry was the observation that both AGY tracking changes in the active site environment and and TCN codons were used to encode active site serines in supporting structures. These markers categorize a variety of enzyme families (Brenner, 1988). Since serine proteases of the chymotrypsin-like, subtilisin- AGY®TCN interconversion is an uncommon event, it like and a/b-hydrolase fold clans according to phylo- was reasoned that enzymes within the same family genetic lineages, and indicate the relative ages and utilizing different active site codons belonged to different order of appearance of those lineages.
  • Amino Acid Building Block Models – in Brief

    Amino Acid Building Block Models – in Brief

    Amino Acid Building Block Models – In Brief Key Teaching Points for Amino Acid Building Block Models© Overall Student Learning Objective: What Dictates How a Protein Folds? Amino acids are the building blocks of proteins. All amino acids have an identical core structure consisting of an alpha-carbon, carboxyl group, amino group and R-group (sidechain). A linear chain of amino acids is a polypeptide. The primary sequence of a protein is the linear sequence of amino acids in a polypeptide. Proteins are made up of amino acid monomers linked together by peptide bonds. Peptide bond formation between amino acids results in the release of water (dehydration synthesis or condensation reaction). The protein backbone is characterized by the “N-C-C-N-C-C. .” pattern. The “ends” of the protein can be identified by the N-terminus (amino group) end and the C-terminus (carboxyl group) end. For a more complete lesson guide, please visit: http://www.3dmoleculardesigns.com/3DMD-Files/AABB/ContentsandAssembly.pdf Amino Acid Core Structure Build an amino acid according to the diagram to the right: 1. Identify the alpha carbon, amino group, carboxyl group and R-group (sidechain representation) in the structure you have constructed. Two amino acids can be chemically linked by a reaction called “condensation” or “dehydration synthesis” to form a dipeptide bond linking the two amino acids. A chain of amino acid units (monomers) linked together by peptide bonds is called a polypeptide. General Dipeptide Structure Construct a model of a dipeptide using the amino acid models previously built. 2. What are the products of the condensation reaction (dehydration synthesis)? 3.
  • Introduction to Proteins and Amino Acids Introduction

    Introduction to Proteins and Amino Acids Introduction

    Introduction to Proteins and Amino Acids Introduction • Twenty percent of the human body is made up of proteins. Proteins are the large, complex molecules that are critical for normal functioning of cells. • They are essential for the structure, function, and regulation of the body’s tissues and organs. • Proteins are made up of smaller units called amino acids, which are building blocks of proteins. They are attached to one another by peptide bonds forming a long chain of proteins. Amino acid structure and its classification • An amino acid contains both a carboxylic group and an amino group. Amino acids that have an amino group bonded directly to the alpha-carbon are referred to as alpha amino acids. • Every alpha amino acid has a carbon atom, called an alpha carbon, Cα ; bonded to a carboxylic acid, –COOH group; an amino, –NH2 group; a hydrogen atom; and an R group that is unique for every amino acid. Classification of amino acids • There are 20 amino acids. Based on the nature of their ‘R’ group, they are classified based on their polarity as: Classification based on essentiality: Essential amino acids are the amino acids which you need through your diet because your body cannot make them. Whereas non essential amino acids are the amino acids which are not an essential part of your diet because they can be synthesized by your body. Essential Non essential Histidine Alanine Isoleucine Arginine Leucine Aspargine Methionine Aspartate Phenyl alanine Cystine Threonine Glutamic acid Tryptophan Glycine Valine Ornithine Proline Serine Tyrosine Peptide bonds • Amino acids are linked together by ‘amide groups’ called peptide bonds.
  • Supplemental Methods

    Supplemental Methods

    Supplemental Methods: Sample Collection Duplicate surface samples were collected from the Amazon River plume aboard the R/V Knorr in June 2010 (4 52.71’N, 51 21.59’W) during a period of high river discharge. The collection site (Station 10, 4° 52.71’N, 51° 21.59’W; S = 21.0; T = 29.6°C), located ~ 500 Km to the north of the Amazon River mouth, was characterized by the presence of coastal diatoms in the top 8 m of the water column. Sampling was conducted between 0700 and 0900 local time by gently impeller pumping (modified Rule 1800 submersible sump pump) surface water through 10 m of tygon tubing (3 cm) to the ship's deck where it then flowed through a 156 µm mesh into 20 L carboys. In the lab, cells were partitioned into two size fractions by sequential filtration (using a Masterflex peristaltic pump) of the pre-filtered seawater through a 2.0 µm pore-size, 142 mm diameter polycarbonate (PCTE) membrane filter (Sterlitech Corporation, Kent, CWA) and a 0.22 µm pore-size, 142 mm diameter Supor membrane filter (Pall, Port Washington, NY). Metagenomic and non-selective metatranscriptomic analyses were conducted on both pore-size filters; poly(A)-selected (eukaryote-dominated) metatranscriptomic analyses were conducted only on the larger pore-size filter (2.0 µm pore-size). All filters were immediately submerged in RNAlater (Applied Biosystems, Austin, TX) in sterile 50 mL conical tubes, incubated at room temperature overnight and then stored at -80oC until extraction. Filtration and stabilization of each sample was completed within 30 min of water collection.
  • B Number Gene Name Mrna Intensity Mrna

    B Number Gene Name Mrna Intensity Mrna

    sample) total list predicted B number Gene name assignment mRNA present mRNA intensity Gene description Protein detected - Membrane protein membrane sample detected (total list) Proteins detected - Functional category # of tryptic peptides # of tryptic peptides # of tryptic peptides detected (membrane b0002 thrA 13624 P 39 P 18 P(m) 2 aspartokinase I, homoserine dehydrogenase I Metabolism of small molecules b0003 thrB 6781 P 9 P 3 0 homoserine kinase Metabolism of small molecules b0004 thrC 15039 P 18 P 10 0 threonine synthase Metabolism of small molecules b0008 talB 20561 P 20 P 13 0 transaldolase B Metabolism of small molecules chaperone Hsp70; DNA biosynthesis; autoregulated heat shock b0014 dnaK 13283 P 32 P 23 0 proteins Cell processes b0015 dnaJ 4492 P 13 P 4 P(m) 1 chaperone with DnaK; heat shock protein Cell processes b0029 lytB 1331 P 16 P 2 0 control of stringent response; involved in penicillin tolerance Global functions b0032 carA 9312 P 14 P 8 0 carbamoyl-phosphate synthetase, glutamine (small) subunit Metabolism of small molecules b0033 carB 7656 P 48 P 17 0 carbamoyl-phosphate synthase large subunit Metabolism of small molecules b0048 folA 1588 P 7 P 1 0 dihydrofolate reductase type I; trimethoprim resistance Metabolism of small molecules peptidyl-prolyl cis-trans isomerase (PPIase), involved in maturation of b0053 surA 3825 P 19 P 4 P(m) 1 GenProt outer membrane proteins (1st module) Cell processes b0054 imp 2737 P 42 P 5 P(m) 5 GenProt organic solvent tolerance Cell processes b0071 leuD 4770 P 10 P 9 0 isopropylmalate
  • Methionine Aminopeptidase Emerging Role in Angiogenesis

    Methionine Aminopeptidase Emerging Role in Angiogenesis

    Chapter 2 Methionine Aminopeptidase Emerging role in angiogenesis Joseph A. Vetro1, Benjamin Dummitt2, and Yie-Hwa Chang2 1Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Ave., Lawrence, KS 66047, USA. 2Edward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University Health Sciences Center, 1402 S. Grand Blvd., St. Louis, MO 63104, USA. Abstract: Angiogenesis, the formation of new blood vessels from existing vasculature, is a key factor in a number of vascular-related pathologies such as the metastasis and growth of solid tumors. Thus, the inhibition of angiogenesis has great potential as a therapeutic modality in the treatment of cancer and other vascular-related diseases. Recent evidence suggests that the inhibition of mammalian methionine aminopeptidase type 2 (MetAP2) catalytic activity in vascular endothelial cells plays an essential role in the pharmacological activity of the most potent small molecule angiogenesis inhibitors discovered to date, the fumagillin class. Methionine aminopeptidase (MetAP, EC 3.4.11.18) catalyzes the non-processive, co-translational hydrolysis of initiator N-terminal methionine when the second residue of the nascent polypeptide is small and uncharged. Initiator Met removal is a ubiquitous and essential modification. Indirect evidence suggests that removal of initiator Met by MetAP is important for the normal function of many proteins involved in DNA repair, signal transduction, cell transformation, secretory vesicle trafficking, and viral capsid assembly and infection. Currently, much effort is focused on understanding the essential nature of methionine aminopeptidase activity and elucidating the role of methionine aminopeptidase type 2 catalytic activity in angiogenesis. In this chapter, we give an overview of the MetAP proteins, outline the importance of initiator Met hydrolysis, and discuss the possible mechanism(s) through which MetAP2 inhibition by the fumagillin class of angiogenesis inhibitors leads to cytostatic growth arrest in vascular endothelial cells.
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier Et Al

    US 200601 10747A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier et al. (43) Pub. Date: May 25, 2006 (54) PROCESS FOR IMPROVED PROTEIN (60) Provisional application No. 60/591489, filed on Jul. EXPRESSION BY STRAIN ENGINEERING 26, 2004. (75) Inventors: Thomas M. Ramseier, Poway, CA Publication Classification (US); Hongfan Jin, San Diego, CA (51) Int. Cl. (US); Charles H. Squires, Poway, CA CI2O I/68 (2006.01) (US) GOIN 33/53 (2006.01) CI2N 15/74 (2006.01) Correspondence Address: (52) U.S. Cl. ................................ 435/6: 435/7.1; 435/471 KING & SPALDING LLP 118O PEACHTREE STREET (57) ABSTRACT ATLANTA, GA 30309 (US) This invention is a process for improving the production levels of recombinant proteins or peptides or improving the (73) Assignee: Dow Global Technologies Inc., Midland, level of active recombinant proteins or peptides expressed in MI (US) host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant (21) Appl. No.: 11/189,375 protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recom (22) Filed: Jul. 26, 2005 binant protein expression. The process can improve protein production or can improve protein quality, for example, by Related U.S. Application Data increasing solubility of a recombinant protein. Patent Application Publication May 25, 2006 Sheet 1 of 15 US 2006/0110747 A1 Figure 1 09 010909070£020\,0 10°0 Patent Application Publication May 25, 2006 Sheet 2 of 15 US 2006/0110747 A1 Figure 2 Ester sers Custer || || || || || HH-I-H 1 H4 s a cisiers TT closers | | | | | | Ya S T RXFO 1961.
  • Introduction 1.1 Post-Translational Modifications

    Introduction 1.1 Post-Translational Modifications

    Chapter I: Introduction 1.1 Post-translational modifications Post-translational modifications (PTMs) are responsible for dynamic regulation of protein structure and function (Jensen et al., 2006). One example of the function of post-translational modifications in the dynamic regulation of protein structure and function is signal transduction; post-translational modification of key regulatory proteins in signal transduction pathways controls cellular proliferation, metabolism, gene expression, cytoskeletal organization and apoptosis (Jensen et al., 2006). Post-translational modifications not only change the mass of the protein, they are also often responsible for changes in charge, structure and conformation. This leads to changes in the biological activity of proteins like enzymes, the binding affinity of proteins to receptors and other protein-protein interactions (Hoffmann et al., 2008) (Murray et al., 1998). For example, the interaction of the cytokine TGF-beta with its receptor complex results in the phosphorylation of SMAD family proteins which activates these proteins to regulate target gene expression (Massague et al., 2000). Post-translational modified amino acid residues can act as binding sites on proteins for a specific recognition domain on other proteins. For example, phosphorylated tyrosine residues can bind to SH2 or PTB domains (Pawson et al., 1997). Depending on the type of PTM they can be very abundant and have a large number of target proteins, whereas other PTM`s have only a few target proteins. Moreover, some PTM`s are connected with several different residues and not only with one residue. For example multi-site phosphorylation that primarily targets Serine, Threonine and Tyrosine residues is a crucial mechanism for the regulation of protein localization and functional activity (Cohen et al., 2000).
  • Peptides & Proteins

    Peptides & Proteins

    Peptides & Proteins (thanks to Hans Börner) 1 Proteins & Peptides Proteuos: Proteus (Gr. mythological figure who could change form) proteuo: „"first, ref. the basic constituents of all living cells” peptos: „Cooked referring to digestion” Proteins essential for: Structure, metabolism & cell functions 2 Bacterium Proteins (15 weight%) 50% (without water) • Construction materials Collagen Spider silk proteins 3 Proteins Structural proteins structural role & mechanical support "cell skeleton“: complex network of protein filaments. muscle contraction results from action of large protein assemblies Myosin und Myogen. Other organic material (hair and bone) are also based on proteins. Collagen is found in all multi cellular animals, occurring in almost every tissue. • It is the most abundant vertebrate protein • approximately a quarter of mammalian protein is collagen 4 Proteins Storage Various ions, small molecules and other metabolites are stored by complexation with proteins • hemoglobin stores oxygen (free O2 in the blood would be toxic) • iron is stored by ferritin Transport Proteins are involved in the transportation of particles ranging from electrons to macromolecules. • Iron is transported by transferrin • Oxygen via hemoglobin. • Some proteins form pores in cellular membranes through which ions pass; the transport of proteins themselves across membranes also depends on other proteins. Beside: Regulation, enzymes, defense, functional properties 5 Our universal container system: Albumines 6 zones: IA, IB, IIA, IIB, IIIA, IIIB; IIB and
  • Studies of Structure and Function of Tripeptidyl-Peptidase II

    Studies of Structure and Function of Tripeptidyl-Peptidase II

    Till familj och vänner List of Papers This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I. Eriksson, S.; Gutiérrez, O.A.; Bjerling, P.; Tomkinson, B. (2009) De- velopment, evaluation and application of tripeptidyl-peptidase II se- quence signatures. Archives of Biochemistry and Biophysics, 484(1):39-45 II. Lindås, A-C.; Eriksson, S.; Josza, E.; Tomkinson, B. (2008) Investiga- tion of a role for Glu-331 and Glu-305 in substrate binding of tripepti- dyl-peptidase II. Biochimica et Biophysica Acta, 1784(12):1899-1907 III. Eklund, S.; Lindås, A-C.; Hamnevik, E.; Widersten, M.; Tomkinson, B. Inter-species variation in the pH dependence of tripeptidyl- peptidase II. Manuscript IV. Eklund, S.; Kalbacher, H.; Tomkinson, B. Characterization of the endopeptidase activity of tripeptidyl-peptidase II. Manuscript Paper I and II were published under maiden name (Eriksson). Reprints were made with permission from the respective publishers. Contents Introduction ..................................................................................................... 9 Enzymes ..................................................................................................... 9 Enzymes and pH dependence .............................................................. 11 Peptidases ................................................................................................. 12 Serine peptidases ................................................................................. 14 Intracellular protein
  • Structure and Synthesis of Antifungal Disulfide

    Structure and Synthesis of Antifungal Disulfide

    microorganisms Review Structure and Synthesis of Antifungal Disulfide β-Strand Proteins from Filamentous Fungi Györgyi Váradi 1,*, Gábor K. Tóth 1,2 and Gyula Batta 3 1 Department of Medical Chemistry, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary; [email protected] 2 MTA-SZTE Biomimetic Systems Research Group, University of Szeged, H-6720 Szeged, Hungary 3 Department of Organic Chemistry, University of Debrecen, H-4032 Debrecen, Hungary; [email protected] * Correspondence: [email protected]; Tel.: +36-62-545-142; Fax: +36-62-545-971 Received: 20 November 2018; Accepted: 24 December 2018; Published: 27 December 2018 Abstract: The discovery and understanding of the mode of action of new antimicrobial agents is extremely urgent, since fungal infections cause 1.5 million deaths annually. Antifungal peptides and proteins represent a significant group of compounds that are able to kill pathogenic fungi. Based on phylogenetic analyses the ascomycetous, cysteine-rich antifungal proteins can be divided into three different groups: Penicillium chrysogenum antifungal protein (PAF), Neosartorya fischeri antifungal protein 2 (NFAP2) and “bubble-proteins” (BP) produced, for example, by P. brevicompactum. They all dominantly have β-strand secondary structures that are stabilized by several disulfide bonds. The PAF group (AFP antifungal protein from Aspergillus giganteus, PAF and PAFB from P. chrysogenum, Neosartorya fischeri antifungal protein (NFAP)) is the best characterized with their common β-barrel tertiary structure. These proteins and variants can efficiently be obtained either from fungi production or by recombinant expression. However, chemical synthesis may be a complementary aid for preparing unusual modifications, e.g., the incorporation of non-coded amino acids, fluorophores, or even unnatural disulfide bonds.